Residual Unexplained Variability

Residual Unexplained Variability is the variability in observed drug concentration measurements that remains after accounting for all known sources of pharmacokinetic variability, including structural model errors, parameter variability, and assay measurement noise, within the context of population pharmacokinetic modeling.

50

Publications

5.5K

Citations

168

Authors

76

Institutions

Publications per year

2017–2026

4

Authors

168

  1. IN
    Ivan Nestorov

    Biogen (United States), United States

    2 publications · 74 citations

    2

    h-index

  2. JS
    Juvêncio S. Nobre

    Universidade Federal do Ceará, Brazil

    2 publications · 210 citations

    2

    h-index

  3. RS
    Richard Simon

    National Cancer Institute, United States

    2 publications · 100 citations

    2

    h-index

  4. RF
    Robert F. Ling

    Clemson University, United States

    2 publications · 2.7K citations

    2

    h-index

  5. RB
    Rahul Balasaheb Aher

    Jadavpur University, India

    2 publications · 848 citations

    2

    h-index

1–5 of 168

Venues

  1. The American Statistician

    2 publications · 100 citations

    2

    h-index

  2. Biometrical Journal

    2 publications · 210 citations

    2

    h-index

  3. 2

    h-index

  4. Technometrics

    2 publications · 2.7K citations

    2

    h-index

  5. Nuclear Physics A

    2 publications · 31 citations

    2

    h-index

1–5